98%
921
2 minutes
20
Type VI CRISPR-Cas systems contain a single effector nuclease (Cas13) that exclusively targets single-stranded RNA. It remains unknown how these systems acquire spacers. It has been suggested that type VI systems with adaptation modules can acquire spacers from RNA bacteriophages, but sequence similarities suggest that spacers may provide immunity to DNA phages. We searched databases for Cas13 proteins with linked RTs. We identified two different type VI-A systems with adaptation modules including an RT-Cas1 fusion and Cas2 proteins. Phylogenetic reconstruction analyses revealed that these adaptation modules were recruited by different effector Cas13a proteins, possibly from RT-associated type III-D systems within the bacterial classes Alphaproteobacteria and Clostridia. These type VI-A systems are predicted to acquire spacers from RNA molecules, paving the way for future studies investigating their role in bacterial adaptive immunity and biotechnological applications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753606 | PMC |
http://dx.doi.org/10.3389/fmicb.2019.02160 | DOI Listing |
Cell Host Microbe
August 2025
Department of Microbiology, University of Washington, Seattle, WA 98109, USA. Electronic address:
CRISPR-Cas systems confer adaptive immunity to their prokaryotic hosts through the process of adaptation, where sequences are captured from foreign nucleic acids and integrated as spacers in the CRISPR array, thereby enabling crRNA-guided interference against new threats. While the Cas1-2 integrase is critical for adaptation, it is absent from many CRISPR-Cas loci, rendering the mechanism of spacer acquisition unclear for these systems. In this study, we show that the RNA-targeting type VI-A CRISPR system of Listeria seeligeri acquires spacers from DNA substrates through the action of a promiscuous Cas1-2 integrase encoded by a co-occurring type II-C system, in a transcription-independent manner.
View Article and Find Full Text PDFInt J Mol Sci
June 2025
Research Centre for Medical Genetics, 115522 Moscow, Russia.
Osteogenesis imperfecta type VI is a rare autosomal recessive disorder characterized by bone fragility and defective mineralization, caused by pathogenic variants in the gene. This study aimed to expand the understanding of OI type VI by analyzing clinical, radiological, and molecular findings in four patients from three unrelated families. Genotyping revealed two novel variants, c.
View Article and Find Full Text PDFInt J Womens Dermatol
October 2025
Plastic and Reconstructive Surgery Department, University of Pretoria. Pretoria, South Africa.
Background: Melasma is a common chronic form of cutaneous hyperpigmentation, particularly prevalent in individuals with Fitzpatrick skin phototypes IV-VI, and it predominantly affects the facial areas of women. The patients with melasma often experience a significant reduction in quality of life. Treating melasma is challenging, as no single gold-standard therapy exists, and higher concentrations (>30%) of trichloroacetic acid peels have been inadequately studied in darker skin phototypes due to the potential complications.
View Article and Find Full Text PDFFASEB J
June 2025
College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
The CRISPR-Cas system is a crucial adaptive immune mechanism in prokaryotes, providing defense against invading genetic elements. Among various CRISPR-Cas systems, the type VI-A system, employing RNA-guided RNase Cas13a, has been extensively studied for its ability to target and degrade single-stranded RNA. Anti-CRISPR (Acr) proteins have evolved as natural inhibitors of these systems, with AcrVIA proteins specifically targeting the Cas13a enzyme.
View Article and Find Full Text PDFJ Indian Assoc Pediatr Surg
February 2025
Department of Pediatric Surgery, Christian Medical College, Vellore, Tamil Nadu, India.
Choledochal cyst(CDC) originating from the cystic duct (Type VI A) is uncommon. Dilatation of both the common bile duct (CBD) and cystic duct (Type VI B) is exceptionally rare in children, with only a handful of adult cases documented in medical literature to date. We report a case of a 1-year-old child who was diagnosed with a Type VI B CDC involving dilation of both the cystic and CBDs, confirmed by imaging and histopathology following cholecystectomy, cyst excision, and hepaticoduodenostomy.
View Article and Find Full Text PDF